StonvexLoading…
StonvexCore line items from VLTO's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.50B | $5.19B | $5.02B | $4.87B |
Operating Income | $1.28B | $1.21B | $1.14B | $1.11B |
Net Income | $940.00M | $833.00M | $839.00M | $845.00M |
EPS (Diluted) | $3.76 | $3.34 | $3.40 | $3.43 |
Total Assets | $7.69B | $6.41B | $5.69B | $4.83B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $2.03B | $1.10B | $762.00M | $0.00 |
Free Cash Flow OCF − CapEx | $1.01B | $820.00M | $909.00M | $836.00M |
Shares Outstanding | 248.40M | 247.40M | 246.30M | 100 |